期刊文献+

独活寄生汤免煎颗粒剂对类风湿性关节炎模型鼠破骨细胞影响随机平行对照研究 被引量:9

Duhuojisheng Decoction and Granule Osteoclast Effect on Rheumatoid Arthritis Model Rats Were Randomized Parallel Controlled Study
原文传递
导出
摘要 [目的]探讨独活寄生汤对类风湿关节炎(RA)模型大鼠骨损伤的保护作用及其机制。[方法]建立II型胶原蛋白诱导的SD大鼠关节炎模型。将60只SD大鼠随机分成4组:空白组、模型组、来氟米特片组和独活寄生汤颗粒剂组,分别给予相应的药液灌胃,持续6周。采用原位杂交法测定大鼠血清中OPG、RANKL的表达水平。[结果]模型组与空白组相比,血清RANKL的平均光密度值明显升高,血清OPG的平均光密度值则明显降低(P<0.05)。[结论]独活寄生汤配方颗粒剂通过上调模型鼠血清中OPG表达,提高OPG/RANKL的比例,竞争性抑制RANK和RANKL的结合,从而有效延缓RA的骨侵蚀。 [Objective]Investigate Duhuojisheng Decoction on rheumatoid arthritis(RA) protective effect and mechanism of bone injury model of rats.[Methods]Establishment of type II collagen induced arthritis rat model of SD.60 SD rats were randomly divided into 4 groups: blank group,model group,leflunomide tablets group and Duhuo Jisheng Decoction granules group,were given by gavage for 6 weeks.To measure the expression of OPG,RANKL in serum of rats by in situ hybridization.[Results]The model group compared with the control group,the average optical density and the value of serum RANKL increased significantly,the average optical density value of the serum OPG was decreased significantly(P〈0.05).[Conclusion] Duhuojisheng Decoction granules through the expression of serum OPG increased in rat model,to improve the ratio of OPG / RANKL,combined with the competitive inhibition of RANK and RANKL,thus effectively delay the RA bone erosion.
作者 杨晓娇 张杰
出处 《实用中医内科杂志》 2013年第3期81-83,共3页 Journal of Practical Traditional Chinese Internal Medicine
关键词 类风湿性关节炎 破骨细胞 骨保护素(OPG) 细胞核因子KB受体活化因子配基(RANKL) 独活寄生汤 来氟米特 随机平行对照研究 Rheumatoid arthritis Osteoblasts Osteoprotegerin(OPG) Nuclear factor of activated KB receptors ligand(RANKL) Duhuojisheng Decoction Leflunomide Randomized controlled study
  • 相关文献

参考文献4

二级参考文献41

  • 1田庆显,黄公怡.OPG/RANK/RANKL系统和骨质疏松[J].中华骨科杂志,2004,24(11):683-686. 被引量:11
  • 2Glantsehnig H, Fisher JE, Wesolowski G, et al. M- CSF, TNFa and RANK ligand promote osteoclast survival by sig- naling through roTOR/S6 kinase [J]. Cell Death Differ, 2003,10(10) :1165- 1177.
  • 3Takahashi N, Maeda K, Ishihara A, et al. Regulatory mecha- nism of osteoelastogenesis by RANKL and Wnt signals[J]. Front Biosci, 2011,16 : 21 - 30.
  • 4Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.[J]. Nature, 1999,402 (6759) : 304 - 309.
  • 5Kohli SS, Kohli VS. Role of RANKL - RANK/osteoprote- gerin molecular complex in bone remodeling and its immuno- pathologic implications[J]. Indian. J Endocrinol Metab,2011, 15(3) :175- 181.
  • 6Leibbrandt A, Penninger JM. Novel functions of RANK (L) signaling in the immune system [J]. Adv Exp Med Biol, 20t0,658 : 77 - 94.
  • 7Mizukami J, Takaesu G, Akatsuka H, et al. Receptor activa- tor of NF- kappaB 'ligand (RANKL) activates TAK1 mito- gen- activated protein kinase kinase kinase through a signa- ling complex containing RANK, TAB2, and TRAF6[J]. Mol Cell Biol,2002,22(4) :992- 1000.
  • 8Armstrong AP,Tometsko ME,Glaeeum M, et al. A RANK/ TRAF6 - dependent signal transduction pathway is essential for osteoelast cytoskeletal organization and resorptive func- tion[J] J Biol Chem,2002,277(46) :44347 - 44356.
  • 9Yavropoulou MP,Yovos JG. Osteoclastogenesis - Current knowledge and future perspectives[J]. J Museuloskelet Neu- ronal Interaet,2008,8(3) 1204 - 216.
  • 10Xing L, Bushnell TP, Carlson L, et al. NF- kappaB p50 and p52 expression is not required for RANK - expressing osteoclast progenitor formation but is essential for RANK - and eytokine- mediated osteoelastogenesis[J]. J Bone Miner Res, 2002,17(7) :1200 - 1210.

共引文献15

同被引文献172

引证文献9

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部